In HCC, the expression of SLC7A11 is also higher in patients at later stages (Stage III + IV, Grade G3 + G4) compared to those at earlier stages (Stage I + II, Grade G1 + G2). Here, SLC7A11 is linked to hepatocellular carcinoma.